Cardiovascular devices

Two areas of heart disease in want of therapeutic solutions are attracting device innovation: atrial fibrillation and congestive heart failure. Successful developers will be rewarded by large markets with little in terms of current competition.

Among the greatest strides made in health care in the latter part of the twentieth century were advances in treating heart disease. While coronary artery disease remains the single leading cause of death in the US, killing more than 500,000 Americans each year, the death rate over the last half century has dropped by half and the onset of heart disease has been pushed back generally by 15 to 20 years. Medical device developments like balloon-tipped catheters, coronary stents and heart stabilizers played a key role in that process, facilitating new clinical techniques such as angioplasty and coronary artery bypass graft surgery. Those innovations were, of course, accompanied by improvements in diagnostic imaging technologies and pharmaceuticals.

The future of cardiovascular devices lies both in refining existing devices (e.g., coated stents and smaller stents for smaller vessels,...

More from Archive

More from Medtech Insight

Burden Is Too Heavy For Medtechs To Go It Alone On Complex Medtech AI Projects

 

Medtech companies require expertise to navigate complex AI regulations and integrate AI in medical software while addressing regulatory challenges, claims expert AI consultant with medtech experience.

Ochsner Surgeon In ‘The Big Easy’ Eases Patient’s Pain With Skill And Virtual Reality

 

A surgeon at Ochsner Health in New Orleans was able to successfully remove a rare and dangerous tumor from a patient’s spine using cutting-edge technology that would have otherwise made the procedure too risky.

Execs On The Move: June 30–July 4, 2025

 
• By 

An interactive look at recent executive-level company changes and promotions in the medical device and diagnostics industries.